1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Are Blood Borne Cancers Treatable with Stem Cell Techniques or other New Advances?"}],["$","meta","1",{"name":"description","content":"NCI and Dana-Farber Science Writers’ Seminar\n
\n
\nWelcome and Message from Dana-Farber’s Director on its role as an NCI-Designated Comprehensive Cancer Center\n
\n
\nKen Anderson, M.D., Dana-Farber – Multiple Myeloma: New therapies using old drugs (e.g., thalidomide)\n
\n
\nRobert Soiffer, M.D., Dana-Farber – Stem Cell Transplantation as a Tool for Treating Blood-borne Cancers\n
\n
\nMr./Mrs. X (Patient at Dana-Farber) – What it means to be a survivor of a blood-borne cancer and the role of Dana-Farber in treatment\n
\n
\nWyndam Wilson, M.D. – The latest advances in leukemia research and where the cancer community is headed in treating blood-borne cancers\n
"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Are Blood Borne Cancers Treatable with Stem Cell Techniques or other New Advances?"}],["$","meta","4",{"property":"og:description","content":"NCI and Dana-Farber Science Writers’ Seminar\n
\n
\nWelcome and Message from Dana-Farber’s Director on its role as an NCI-Designated Comprehensive Cancer Center\n
\n
\nKen Anderson, M.D., Dana-Farber – Multiple Myeloma: New therapies using old drugs (e.g., thalidomide)\n
\n
\nRobert Soiffer, M.D., Dana-Farber – Stem Cell Transplantation as a Tool for Treating Blood-borne Cancers\n
\n
\nMr./Mrs. X (Patient at Dana-Farber) – What it means to be a survivor of a blood-borne cancer and the role of Dana-Farber in treatment\n
\n
\nWyndam Wilson, M.D. – The latest advances in leukemia research and where the cancer community is headed in treating blood-borne cancers\n
"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/98be1744-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/4ad34fb6-f89e-4c31-b37e-004cc5e76cce.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Are Blood Borne Cancers Treatable with Stem Cell Techniques or other New Advances?"}],["$","meta","11",{"name":"twitter:description","content":"NCI and Dana-Farber Science Writers’ Seminar\n
\n
\nWelcome and Message from Dana-Farber’s Director on its role as an NCI-Designated Comprehensive Cancer Center\n
\n
\nKen Anderson, M.D., Dana-Farber – Multiple Myeloma: New therapies using old drugs (e.g., thalidomide)\n
\n
\nRobert Soiffer, M.D., Dana-Farber – Stem Cell Transplantation as a Tool for Treating Blood-borne Cancers\n
\n
\nMr./Mrs. X (Patient at Dana-Farber) – What it means to be a survivor of a blood-borne cancer and the role of Dana-Farber in treatment\n
\n
\nWyndam Wilson, M.D. – The latest advances in leukemia research and where the cancer community is headed in treating blood-borne cancers\n
"}],["$","meta","12",{"name":"twitter:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/4ad34fb6-f89e-4c31-b37e-004cc5e76cce.jpg"}],["$","link","13",{"rel":"icon","href":"/favicon.ico","type":"image/x-icon","sizes":"512x512"}],"$L22"],"error":null,"digest":"$undefined"}